Impact of Non–Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective-Reference-Cited by-同舟云学术

Impact of Non–Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective

Published:2017-10 Issue:10 Volume:37 Page:1812-1818
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Hoffman Maureane¹,Monroe Dougald M.¹

Affiliation:

1. From the Pathology and Laboratory Medicine Service, Durham Veterans Affairs Medical Center, NC (M.H.); Department of Pathology, Duke University Medical Center, Durham, NC (M.H.); McAlister Heart Institute, Chapel Hill, NC (M.H., D.M.M.); and Department of Medicine, the University of North Carolina, Chapel Hill (M.H., D.M.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. The story of the discovery of heparin and warfarin

2. ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM

3. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

4. Antithrombotic Therapy for VTE Disease

5. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Non-vitamin K antagonist oral anticoagulants in adults with congenital heart disease;International Journal of Arrhythmia;2022-09-01

3. Coagulation and Anticoagulation in Fontan Patients;Canadian Journal of Cardiology;2022-07

4. (Absence of) Association Between Non–Vitamin K Antagonist Oral Anticoagulant Therapy and Urinary Tract Infection in Patients With Atrial Fibrillation;Journal of Cardiovascular Pharmacology;2021-06

5. Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants;The American Journal of Emergency Medicine;2021-05